Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors
about
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFRLung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.Treating EGFR mutation resistance in non-small cell lung cancer - role of osimertinib.Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment.Pharmacokinetic drug evaluation of osimertinib for the treatment of non-small cell lung cancer.Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance.Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors.Olmutinib Induced Lichen Planus Like EruptionOlmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 and
P2860
Q33618558-92D80744-83FE-499B-8D54-5808CF55793DQ40070868-80534110-D69D-4BAD-B105-785FEFBE1018Q41189462-CB07F871-787C-46D3-B3FB-8ECE264DD8C1Q46328392-03582262-2A88-4A99-94B3-B3DA57CE9E10Q47450308-E3E687A4-1974-4B96-AE72-C53B34EAFB54Q48205769-CC0AD2C2-E2A8-48C3-B78D-94E223052A0AQ49887919-1542F7A5-06B6-458F-882A-455A5BD04236Q57210987-EF07FA01-8958-410C-A1B2-B347B43A945FQ57211312-B1E8469B-B2EE-4709-82DC-5B830BD3A511
P2860
Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Update on recent preclinical a ...... tor tyrosine kinase inhibitors
@ast
Update on recent preclinical a ...... tor tyrosine kinase inhibitors
@en
Update on recent preclinical a ...... tor tyrosine kinase inhibitors
@nl
type
label
Update on recent preclinical a ...... tor tyrosine kinase inhibitors
@ast
Update on recent preclinical a ...... tor tyrosine kinase inhibitors
@en
Update on recent preclinical a ...... tor tyrosine kinase inhibitors
@nl
prefLabel
Update on recent preclinical a ...... tor tyrosine kinase inhibitors
@ast
Update on recent preclinical a ...... tor tyrosine kinase inhibitors
@en
Update on recent preclinical a ...... tor tyrosine kinase inhibitors
@nl
P2093
P2860
P921
P1476
Update on recent preclinical a ...... tor tyrosine kinase inhibitors
@en
P2093
Chia-Chi Lin
James Chih-Hsin Yang
Jih-Hsiang Lee
P2860
P2888
P356
10.1186/S12929-016-0305-9
P407
P50
P5008
P577
2016-12-03T00:00:00Z
P6179
1003760296